Suchergebnisse - "Cannita, Katia"

PubPharm (7)

1

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors : A multicentre analysis of immune-related adverse events

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Cortellini, A. | Bersanelli, M. | Santini, D. | +35

2

Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors : a multicenter real-life study

enthalten in: Scientific reports | 2020

von Cortellini, A. | Bozzetti, F. | Palumbo, P. | +17

3

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors : the multicenter FAMI-L1 study

enthalten in: Oncoimmunology | 2020

von Cortellini, A. | Buti, S. | Bersanelli, M. | +46

4

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

enthalten in: Clinical lung cancer | 2019

von Cortellini, A. | Chiari, R. | Ricciuti, B. | +32

5

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy : A Real-World Transverse Study

enthalten in: The oncologist | 2019

von Cortellini, A. | Buti, S. | Santini, D. | +42

6

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors : when overweight becomes favorable

enthalten in: Journal for immunotherapy of cancer | 2019

von Cortellini, A. | Bersanelli, M. | Buti, S. | +42

7

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents : preliminary report of the FAMI-L1 study

enthalten in: Immunotherapy | 2018

von Cortellini, A. | Bersanelli, M. | Buti, S. | +20

1
[1]